ALS Therapy Development Institute partnered with the Muscular Dystrophy Association to fund the Champion Insights study, which aims to understand why fire fighters face a higher risk of ALS.
Public source
Publisher name
Public post
Grateful to our partners at Muscular Dystrophy Association, whose funding is helping power the Champion Insights study — bringing us closer to understanding why fire fig…
Company
ALS Therapy Development Institute
We are the world's foremost drug discovery lab focused solely on ALS. Our mission is to discover and develop treatments.
- Industry
- Biotechnology Research
- Location
- Watertown, US
- Company size
- 51–200 employees
About ALS Therapy Development Institute
The ALS Therapy Development Institute (ALS TDI) and its researchers discover and develop potential treatments for ALS. It is the world’s first and largest nonprofit biotech focused 100 percent on ALS research. Led by drug development experts and people living with ALS, ALS TDI understands the urgent need to slow and stop this disease. Based in the Greater Boston Area, ALS TDI has over 30 full-time, industry trained, drug development experts on staff. ALS TDI is internationally recognized as a leader in preclinical and translational ALS research, and partners with pharmaceutical companies and biotechs around the world. Rated a four-star nonprofit on Charity Navigator, ALS TDI spends 87 cents of every dollar raised on research to find an effective treatment and cure. Learn more at www.als.net.
See moreLatest activity
Latest activity from ALS Therapy Development Institute
4 signals
Products & Services
ALS Therapy Development Institute created PRISM ALS to develop patient-derived motor neuron models representing sporadic ALS and benchmark them against familial ALS lines.
Products & Services
ALS Therapy Development Institute launched the Multi-condition Patient Registry Mockup, a complete registry data dictionary rendered as the experience a participant would have with 11,000+ questions, a variable library, and a REDCap-format data dictionary.
Presence & Recognition
ALS Therapy Development Institute is holding nominations for the 2026 ALS TDI Leadership Award, which closes this evening.
Discover more
Similar signals
Similar public activity from other companies.
Research & Knowledge
The ALS Association
The ALS Association published a newly published paper examining the damaging consequences of overpromising and overstating early ALS clinical trial results and recurring flaws in trial design and data interpretation.
Research & Knowledge
Vertex Pharmaceuticals
Vertex Pharmaceuticals continues its research in myotonic dystrophy type 1 and other neuromuscular diseases to raise awareness during MuscularDystrophyAwarenessMonth.
Research & Knowledge
VectorY
VectorY completed the dosing of the first European participant in the Phase 1/2 PIONEER-ALS study, occurring only ~50 kilometers from the birthplace of both VectorY and VTx-002.
Research & Knowledge
ZeClinics
ZeClinics published a study by Patten et al. using zebrafish models to evaluate the efficacy of pimozide for ALS.
Research & Knowledge
Translational Neuroscience Strategy